Skip to main content
Livermore
Livermore
ZHEN

Abingworth LLP

SEC CIK
0001397144
Latest filing
Feb 10, 2023

Holdings in Q2 2022

Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.

Institution overview
Positions
21
+1 vs. Q1 2022
Portfolio value
$312.4M
−$40.1M (−11.4%) vs. Q1 2022
Filed
Aug 15, 2022
SEC
Holdings of Abingworth LLP in Q2 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
OCGNOcugen, Inc.Common7,111$16.0K<0.1%00.0%UnchangedHistory
SYRESpyre Therapeutics, Inc.COM240,500$121.0K<0.1%00.0%UnchangedHistory
OBSVObsEva SACOM87,999$141.0K<0.1%00.0%UnchangedHistory
MTEMMolecular Templates, Inc.COM200,000$182.0K0.1%00.0%UnchangedHistory
CBAYCymaBay Therapeutics, Inc.COM131,036$385.0K0.1%00.0%UnchangedHistory
XCURExicure, Inc.COM281,636$594.0K0.2%+49,069+21.1%AddedConverted for a 1-for-30 splitHistory
SIENProject Sage Oldco, Inc.COM1,673,589$1.39M0.4%−676,238−28.8%ReducedHistory
PRTKParatek Pharmaceuticals, Inc.COM1,041,131$2.00M0.6%00.0%UnchangedHistory
NCNANuCana plcSPONSORED ADR3,333,333$2.42M0.8%00.0%UnchangedHistory
Spruce BioE5209E109Common1,792,518$3.10M1.0%00.0%Unchanged–
SLNOSoleno Therapeutics IncCOM NEW18,022,602$3.17M1.0%00.0%UnchangedHistory
OKUROnKure Therapeutics, Inc.COM2,073,957$5.41M1.7%00.0%UnchangedHistory
EFTReFFECTOR Therapeutics, Inc.COM4,822,114$6.46M2.1%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS2,457,500$10.2M3.3%+10.0%AddedHistory
JSPRJasper Therapeutics, Inc.COM5,628,558$10.6M3.4%00.0%UnchangedHistory
PHATPhathom Pharmaceuticals, Inc.COM1,435,106$12.1M3.9%00.0%UnchangedHistory
HLVXHilleVax, Inc.COM1,838,486$19.9M6.4%+1,838,486NewHistory
ACETAdicet Bio, Inc.COM2,115,385$30.9M9.9%00.0%UnchangedHistory
VERAVera Therapeutics, Inc.CL A2,960,231$40.3M12.9%00.0%UnchangedHistory
SRRASierra Oncology, Inc.COM1,314,127$72.3M23.1%+1150.0%AddedHistory
PCVXVaxcyte, Inc.COM4,168,718$90.7M29.0%00.0%UnchangedHistory